HIND

VYOME HOLDINGS INC

HIND·92943X104·US·Common Stock·Healthcare - Biotechnology

HIND (VYOME HOLDINGS INC) is held by 7 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($55,454), UBS Group AG ($48,751), Focus Partners Wealth ($31,476). Net institutional sentiment: Bullish.

7
Holders
(2 Elite)
$195,279
Total Value
71% (7)
Consensus
5 buying - 2 selling
13F: Insider & Congress:

No verdict yet — fewer than 2 funds hold HIND.

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
25,793(+116.1%)$55,4540.0%-31.26%
23
Increased
22,675(+472.8%)$48,7510.0%-29.93%
22
Unchanged
14,640$31,4760.0%-34.59%
0
New
12,195$26,2190.0%-28.12%
29
New
9,463$20,3450.0%-28.12%
29
Unchanged
5,856$13,0000.0%-58.02%
0
Increased
16(+1500.0%)$340.0%-28.56%
12
Exited
0(-100.0%)$550.0%-24.76%
0
Exited
0(-100.0%)$155,2950.0%-9.01%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used